Search results for EIF4EBP1 Antibody

EIF4EBP1 Antibody, Abbexa, abx330243

EIF4EBP1 Antibody is a Rabbit Polyclonal against EIF4EBP1.

eIF4EBP1 Antibody (YA6024), MedChemexpress, HY-P86332

eIF4EBP1 Antibody (YA6024) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to eIF4EBP1.

eIF4EBP1 Antibody (YA650), MedChemexpress, HY-P80526

eIF4EBP1 Antibody (YA650) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to eIF4EBP1.

eIF4EBP1 Antibody (YA462), MedChemexpress, HY-P80119

eIF4EBP1 Antibody (YA462) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to eIF4EBP1.

Anti-eIF4EBP1 antibody, Abcam, AB2606

Anti-EIF4EBP1 Antibody (R2E54), AntibodySystem, RHG57901

Anti-EIF4EBP1 Antibody (R3S64), AntibodySystem, RHG57904

Anti-EIF4EBP1 Antibody (R3S65), AntibodySystem, RHG57905

Anti-eIF4EBP1 antibody [Y329], Abcam, AB32024

Binding of eIF4EBP1 to eIF4E is reversible and is dependent on the phosphorylation status of eIF4EBP1. Non phosphorylated eIF4EBP1 will bind strongly to eIF4E while, the phosphorylated form will not. Akt, TOR, MAP kinase, S6 kinase, and Cdc2 are known kinases capable of inactivating eIF4EBP1 binding to eIF4E by phosphorylating either threonines 35, 45, 69 or serine 64. Although, not all phosphorylation events equally block the eIF4EBP1-eIF4E interaction. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-eIF4EBP1 antibody [Y330], Abcam, AB32130

Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .